Disopyramide Phosphate (AvKARE, Inc.)


Welcome to the PulseAid listing for the Disopyramide Phosphate drug offered from AvKARE, Inc.. This Antiarrhythmic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AvKARE, Inc.
NON-PROPRIETARY NAME: Disopyramide Phosphate
SUBSTANCE NAME: DISOPYRAMIDE PHOSPHATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antiarrhythmic [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2014-01-03
END MARKETING DATE: 0000-00-00


Disopyramide Phosphate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDisopyramide Phosphate from AvKARE, Inc.
LABELER NAME: AvKARE, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/1)
START MARKETING DATE: 2014-01-03
END MARKETING DATE: 0000-00-00
PRODUCT ID: 42291-234_201650d3-2f6b-aaa6-5c13-8edff6813bd6
PRODUCT NDC: 42291-234
APPLICATION NUMBER: ANDA070101

Other DISOPYRAMIDE PHOSPHATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Disopyramide Phosphate
AvKARE, Inc.Disopyramide Phosphate
Carilion Materials ManagementNorpace
G.D. Searle LLC Division of Pfizer IncNorpace CR
Mayne Pharma Inc.Disopyramide Phosphate
Teva Pharmaceuticals USA IncDisopyramide Phosphate